Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luana Naia

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
BMC Medicine|February 25, 2025
Antidepressant use and cognitive decline in patients with dementia: a national cohort studyMinjia Mo, Tamar Abzhandadze, Minh Tuan Hoang, et al.
Human Molecular Genetics|October 4, 2017
The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytesVera Lemos, Rita M de Oliveira, Luana Naia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 27, 2017
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's DiseaseLuana Naia, Teresa Cunha-Oliveira, Joana Rodrigues, et al.
Molecular Neurobiology|September 4, 2016
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease ModelsLuana Naia, Tatiana R Rosenstock, Ana M Oliveira, et al.
Journal of Alzheimer'S Disease : JAD|January 8, 2025
Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patientsPol Grau-Jurado, Shayan Mostafaei, Hong Xu, et al.
Molecular Psychiatry|November 1, 2023
Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse modelsLuana Naia, Makoto Shimozawa, Erika Bereczki, et al.
Journal of Internal Medicine|November 6, 2025
Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic healthSilvia Maioli, Ivan Nalvarte, Maria Ankarcrona, et al.
Molecular Neurobiology|May 21, 2014
Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblastsLuana Naia, I Luísa Ferreira, Teresa Cunha-Oliveira, et al.
Brain : a Journal of Neurology|February 2, 2026
Impairment of hippocampal gamma oscillations, mitochondria and neurovascular function in CADASILWenchao Shao, Daniel V Oliveira, Luana Naia, et al.
Journal of Alzheimer'S Disease Reports|October 6, 2025
Statins, cholesterol and cognition at the time of Alzheimer's disease diagnosis: A cross-sectional study from the Swedish registry for cognitive/dementia disordersBojana Petek, Minjia Mo, Hong Xu, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BMC Medicine|February 25, 2025
Antidepressant use and cognitive decline in patients with dementia: a national cohort studyMinjia Mo, Tamar Abzhandadze, Minh Tuan Hoang, et al.
Human Molecular Genetics|October 4, 2017
The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytesVera Lemos, Rita M de Oliveira, Luana Naia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 27, 2017
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's DiseaseLuana Naia, Teresa Cunha-Oliveira, Joana Rodrigues, et al.
Molecular Neurobiology|September 4, 2016
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease ModelsLuana Naia, Tatiana R Rosenstock, Ana M Oliveira, et al.
Journal of Alzheimer'S Disease : JAD|January 8, 2025
Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patientsPol Grau-Jurado, Shayan Mostafaei, Hong Xu, et al.
Molecular Psychiatry|November 1, 2023
Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse modelsLuana Naia, Makoto Shimozawa, Erika Bereczki, et al.
Journal of Internal Medicine|November 6, 2025
Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic healthSilvia Maioli, Ivan Nalvarte, Maria Ankarcrona, et al.
Molecular Neurobiology|May 21, 2014
Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblastsLuana Naia, I Luísa Ferreira, Teresa Cunha-Oliveira, et al.
Brain : a Journal of Neurology|February 2, 2026
Impairment of hippocampal gamma oscillations, mitochondria and neurovascular function in CADASILWenchao Shao, Daniel V Oliveira, Luana Naia, et al.
Journal of Alzheimer'S Disease Reports|October 6, 2025
Statins, cholesterol and cognition at the time of Alzheimer's disease diagnosis: A cross-sectional study from the Swedish registry for cognitive/dementia disordersBojana Petek, Minjia Mo, Hong Xu, et al.
Pageof 4